Stock report · NASDAQ
Pluri Inc. (PLUR)
…
PLUR stock chart
Loading chart…
Key statistics
About Pluri Inc.
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.
Pluri financials at a glance
Quotes may be delayed. Market data is provided for information only and is not investment advice; see our disclaimer.